| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.03T | 2.07T | 2.08T | 2.28T | 1.59T |
| Gross Profit | 437.52B | 405.58B | 410.37B | 282.22B | 314.77B |
| EBITDA | 358.02B | 339.29B | 343.11B | 224.74B | 246.41B |
| Net Income | 152.75B | 134.41B | 132.68B | 57.11B | 130.42B |
Balance Sheet | |||||
| Total Assets | 3.32T | 3.20T | 2.98T | 2.82T | 2.59T |
| Cash, Cash Equivalents and Short-Term Investments | 58.98B | 82.81B | 77.67B | 85.09B | 131.09B |
| Total Debt | 794.22B | 972.42B | 913.00B | 902.53B | 785.08B |
| Total Liabilities | 1.47T | 1.46T | 1.38T | 1.40T | 1.29T |
| Stockholders Equity | 1.81T | 1.69T | 1.58T | 1.39T | 1.27T |
Cash Flow | |||||
| Free Cash Flow | 102.20B | 72.83B | 137.96B | -138.51B | -28.10B |
| Operating Cash Flow | 340.74B | 283.68B | 312.61B | 33.57B | 145.35B |
| Investing Cash Flow | -241.63B | -233.75B | -215.56B | -203.63B | -161.46B |
| Financing Cash Flow | -129.40B | -55.96B | -110.51B | 119.31B | -21.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥65.98B | 5.70 | ― | 2.88% | 2.48% | 10.65% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | ¥290.21B | 20.25 | 20.44% | 3.28% | 4.21% | 30.94% | |
63 Neutral | ¥2.15T | 13.68 | 10.44% | 1.98% | 1.99% | 95.71% | |
63 Neutral | ¥2.10T | 9.34 | 11.05% | 1.53% | 7.51% | 232.54% | |
61 Neutral | ¥83.05B | 11.22 | 9.07% | 3.61% | 2.90% | 13.95% | |
59 Neutral | ¥468.82B | 14.88 | 6.03% | 1.81% | -0.75% | 33.35% |